Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Focus Area: Manufacturing
ROI: The strong case for EMI Software
By Robert Di Scipio, President and CEO, Aegis Analytical Corp. Today’s emphasis on efficiency has motivated manufacturing companies to search for new tools to help reduce process variability and increase predictability.
The pharma industry in the new decade
Marcel Velterop of Dr Reddy's explains the rise of collaborative working in the industry.
Commercial success
Eurand's Andrew Thompson examines the potential for drug delivery products in emerging markets.
Cross-divisional integrated solutions
The supply chain has become a competitive edge, a sales argument and at the same time, a key area for cost cutting activities. Time to market plays a significant role for the future. By Martin Svantesson
Get real
Travis Johnson of the IACC talks to NGP about the global problem of counterfeit pharmaceuticals.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.